These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25019423)

  • 1. The diagnostic efficacy of nectin 4 expression in ovarian cancer patients.
    Nabih ES; Abdel Motaleb FI; Salama FA
    Biomarkers; 2014 Sep; 19(6):498-504. PubMed ID: 25019423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker.
    Derycke MS; Pambuccian SE; Gilks CB; Kalloger SE; Ghidouche A; Lopez M; Bliss RL; Geller MA; Argenta PA; Harrington KM; Skubitz AP
    Am J Clin Pathol; 2010 Nov; 134(5):835-45. PubMed ID: 20959669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors.
    Alanbay I; Aktürk E; Coksuer H; Ercan CM; Karaşahin E; Dede M; Yenen MC; Ozan H; Dilek S
    Eur J Gynaecol Oncol; 2012; 33(1):25-30. PubMed ID: 22439401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nectin-4 is a new histological and serological tumor associated marker for breast cancer.
    Fabre-Lafay S; Monville F; Garrido-Urbani S; Berruyer-Pouyet C; Ginestier C; Reymond N; Finetti P; Sauvan R; Adélaïde J; Geneix J; Lecocq E; Popovici C; Dubreuil P; Viens P; Gonçalves A; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Lopez M
    BMC Cancer; 2007 May; 7():73. PubMed ID: 17474988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer.
    Sedláková I; Vávrová J; Tošner J; Hanousek L
    Tumour Biol; 2011 Apr; 32(2):311-6. PubMed ID: 21061112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cysteine cathepsin L is a marker of invasion and metastasis in ovarian cancer.
    Zhang W; Wang S; Wang Q; Yang Z; Pan Z; Li L
    Oncol Rep; 2014 Mar; 31(3):1334-42. PubMed ID: 24402045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nidogen-2: a new serum biomarker for ovarian cancer.
    Kuk C; Gunawardana CG; Soosaipillai A; Kobayashi H; Li L; Zheng Y; Diamandis EP
    Clin Biochem; 2010 Mar; 43(4-5):355-61. PubMed ID: 19883638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
    Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
    Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nectin-2 in ovarian cancer: How is it expressed and what might be its functional role?
    Bekes I; Löb S; Holzheu I; Janni W; Baumann L; Wöckel A; Wulff C
    Cancer Sci; 2019 Jun; 110(6):1872-1882. PubMed ID: 30843637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer.
    Takano A; Ishikawa N; Nishino R; Masuda K; Yasui W; Inai K; Nishimura H; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Cancer Res; 2009 Aug; 69(16):6694-703. PubMed ID: 19679554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum progesterone levels in postmenopausal women with mucinous ovarian tumors.
    Matsuoka A; Tate S; Nishikimi K; Ishikawa H; Shozu M
    Menopause; 2016 May; 23(5):544-9. PubMed ID: 26926326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
    Dewan R; Dewan A; Jindal M; Bhardawaj M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of selected serum protein markers as early detectors of ovarian cancer].
    Mrochem J; Sodowski K; Deja R; Walaszek-Gruszka A; Wojcieszek A; Kołosza Z; Chmura A; Czernik E; Masłyk B; Bartnik W; Cnota W
    Ginekol Pol; 2008 Apr; 79(4):271-5. PubMed ID: 18592865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels.
    Lancaster JM; Sayer RA; Blanchette C; Calingaert B; Konidari I; Gray J; Schildkraut J; Schomberg DW; Marks JR; Berchuck A
    Int J Gynecol Cancer; 2006; 16(4):1529-35. PubMed ID: 16884361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
    Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
    Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple MAGE-A genes as surveillance marker for the detection of circulating tumor cells in patients with ovarian cancer.
    Sang M; Wu X; Fan X; Sang M; Zhou X; Zhou N
    Biomarkers; 2014 Feb; 19(1):34-42. PubMed ID: 24320162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.
    Boylan KL; Buchanan PC; Manion RD; Shukla DM; Braumberger K; Bruggemeyer C; Skubitz AP
    Oncotarget; 2017 Feb; 8(6):9717-9738. PubMed ID: 28038455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total inhibin is a potential serum marker for epithelial ovarian cancer.
    Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.